Company
RUA Life Sciences
LON:RUA
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane. Whether it is licensing Elast-EonTM, manufacturing a device or component or developing next generation medical devices, a RUA Life Sciences business is pursuing our vision.
8 stories
Archive
Advanced Medical Solutions brings in expertise with latest acquisition
A look at some of the major movers in London on Monday
Archive
Gaming Realms advances with licencing agreement for Slingo portfolio
A look at Wednesday's major movers on the London Stock Exchange
RUA Life Sciences reports larger loss but eyes key milestones ahead
Revenues grew 5.6% to £489,000, but higher research and development costs led to the loss for the year rising 34% to £816,000